Compare H1B visa sponsorship data between Boston Pharma and Goldman Sachs. See how they stack up on salary, approval rates, and more.
Key Statistics Comparison
Total H1B Filings
4
Boston Pharma
+100.0%
14,154
Goldman Sachs
Median Salary
+32.5%
$150,000
Boston Pharma
$113,200
Goldman Sachs
Approval Rate
100.0%
Boston Pharma
99.0%
Goldman Sachs
Years Sponsoring
3
Boston Pharma
+83.3%
18
Goldman Sachs
Historical Trends
H1B Filings Over Time
Boston Pharma
Goldman Sachs
Median Salary Trend
Boston Pharma
Goldman Sachs
Where & What They Hire
Top H1B Job Categories
Boston Pharma
Pharmacists 2 filings
Goldman Sachs
Software Developers 131 filings
Financial and Investment Analysts 83 filings
Financial Quantitative Analysts 73 filings
Financial Risk Specialists 72 filings
Business Intelligence Analysts 63 filings
Top H1B Work Locations
Boston Pharma
Brooklyn, NY 2 filings
Goldman Sachs
Dallas, TX 249 filings
Salt Lake City, UT 209 filings
New York, NY 169 filings
Jersey City, NJ 14 filings
New York, NY 12 filings
Year-by-Year Breakdown
| Year | Boston Pharma | Goldman Sachs | ||||
|---|---|---|---|---|---|---|
| Filings | Salary | Approval | Filings | Salary | Approval | |
| FY2025 | - | - | - | 731 | $113,200 | 99.0% |
| FY2024 | 2 | $150,000 | 100.0% | 310 | $145,000 | 100.0% |
| FY2023 | - | - | - | 186 | $150,000 | 100.0% |
| FY2022 | - | - | - | 306 | $149,000 | 100.0% |
| FY2021 | - | - | - | 527 | $125,000 | 100.0% |
| FY2020 | 1 | $85,946 | 100.0% | 249 | $138,000 | 100.0% |
| FY2019 | 1 | $104,062 | 100.0% | 1,726 | $115,000 | 98.7% |
| FY2018 | - | - | - | 1,779 | $110,000 | 98.7% |
| FY2017 | - | - | - | 1,085 | $103,600 | 99.0% |
| FY2016 | - | - | - | 1,086 | $105,050 | 98.2% |
Showing most recent 10 years of 18 total
Frequently Asked Questions
- Which company pays higher H1B salaries, Boston Pharma or Goldman Sachs?
- Boston Pharma pays higher H1B salaries with a median of $150,000 compared to Goldman Sachs's $113,200.
- Which company sponsors more H1B visas, Boston Pharma or Goldman Sachs?
- Goldman Sachs has sponsored more H1B visas with 14,154 total filings compared to Boston Pharma's 4.
- How do Boston Pharma and Goldman Sachs H1B approval rates compare?
- Boston Pharma has a 100.0% H1B approval rate while Goldman Sachs has 99.0%. Boston Pharma has a higher approval rate.